← Eichor
Study identifier: NCT07407491 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis

Condition: Acute Cholangitis · Biliary Tract Infection · Biliary Obstruction  ·  Sponsor: National University of Malaysia

PhasePhase 2
Planned participants172
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Does intraductal administration of antibiotics during endoscopic retrograde cholangiopancreatography (ERCP), in addition to standard systemic antibiotic therapy, improve clinical outcomes in patients with acute cholangitis compared with standard systemic antibiotic therapy alone?

This description comes directly from the study's public registry record.

Talk to the study team

Tiew Toot Chaw  ·  +60176175253  ·  warrentiew@gmail.com

Azlanudin Azman  ·  +60192817878  ·  drazlan@ppukm.ukm.my

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Canselor Tuanku Muhriz UKMCheras, Kuala Lumpur, MalaysiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07407491